HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 286 filers reported holding HAEMONETICS CORP in Q2 2020. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,002,222 | +8.0% | 11,188 | +2.6% | 0.20% | +9.1% |
Q2 2023 | $928,197 | +4.1% | 10,902 | +1.1% | 0.19% | +1.1% |
Q1 2023 | $891,963 | +5.2% | 10,779 | -0.0% | 0.18% | +2.8% |
Q4 2022 | $847,847 | +8.7% | 10,780 | +2.3% | 0.18% | -2.7% |
Q3 2022 | $780,000 | +17.3% | 10,542 | +3.3% | 0.18% | +21.7% |
Q2 2022 | $665,000 | +9.2% | 10,205 | +5.9% | 0.15% | +23.6% |
Q1 2022 | $609,000 | +41.3% | 9,637 | +18.7% | 0.12% | +44.7% |
Q4 2021 | $431,000 | -22.1% | 8,121 | +3.7% | 0.08% | -29.2% |
Q3 2021 | $553,000 | +17.4% | 7,828 | +10.8% | 0.12% | +21.2% |
Q2 2021 | $471,000 | -48.0% | 7,067 | -13.4% | 0.10% | -50.5% |
Q1 2021 | $905,000 | -5.5% | 8,156 | +1.1% | 0.20% | -11.9% |
Q4 2020 | $958,000 | +39.4% | 8,068 | +2.5% | 0.23% | +20.1% |
Q3 2020 | $687,000 | +1.5% | 7,872 | +4.1% | 0.19% | -3.1% |
Q2 2020 | $677,000 | -4.6% | 7,561 | +6.0% | 0.20% | -17.0% |
Q1 2020 | $710,000 | -22.1% | 7,130 | -10.1% | 0.24% | -0.8% |
Q4 2019 | $911,000 | -10.1% | 7,927 | -1.4% | 0.24% | -15.4% |
Q3 2019 | $1,013,000 | +3.9% | 8,036 | -0.8% | 0.28% | +1.1% |
Q2 2019 | $975,000 | +35.0% | 8,102 | -1.9% | 0.28% | +34.5% |
Q1 2019 | $722,000 | -10.9% | 8,260 | +2.0% | 0.21% | -22.8% |
Q4 2018 | $810,000 | -10.9% | 8,100 | +2.1% | 0.27% | +3.9% |
Q3 2018 | $909,000 | +28.4% | 7,937 | +0.5% | 0.26% | +20.1% |
Q2 2018 | $708,000 | +24.0% | 7,898 | +1.2% | 0.21% | +19.6% |
Q1 2018 | $571,000 | -33.9% | 7,807 | -47.5% | 0.18% | -31.4% |
Q4 2017 | $864,000 | +28.2% | 14,879 | -1.0% | 0.26% | +22.5% |
Q3 2017 | $674,000 | +24.8% | 15,029 | +10.0% | 0.21% | +19.0% |
Q2 2017 | $540,000 | +13.0% | 13,666 | +16.1% | 0.18% | +3.5% |
Q1 2017 | $478,000 | +2.6% | 11,773 | +1.7% | 0.17% | -2.3% |
Q4 2016 | $466,000 | +29.8% | 11,580 | +16.8% | 0.18% | +25.5% |
Q3 2016 | $359,000 | +39.1% | 9,916 | +11.3% | 0.14% | +34.3% |
Q2 2016 | $258,000 | -10.4% | 8,906 | +8.0% | 0.10% | -13.2% |
Q1 2016 | $288,000 | +21.5% | 8,247 | +12.4% | 0.12% | +9.0% |
Q3 2015 | $237,000 | -9.9% | 7,337 | +15.3% | 0.11% | -3.5% |
Q2 2015 | $263,000 | +13.9% | 6,366 | +23.7% | 0.12% | +17.3% |
Q1 2015 | $231,000 | – | 5,147 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
Dean Capital Management | 15,309 | $812,000 | 0.70% |
Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |